On November 12, 2008, Wang, Lianmin; Liu, Kefei; Zhang, Xu published a patent.Quality Control of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Medicinal composition containing sulfamethoxazole sodium, trimethoprim lactate and maquindox, its formulation and application for preventing and treating duck infectious serositis. And the patent contained the following:
The medical composition is composed of sulfamethoxazole sodium 5-10, trimethoprim lactate 1-2, maquindox 5-10, and pharmaceutically acceptable adjuvant to 100 g. The adjuvant in the medical composition is from sucrose, anhydrous glucose, or oral glucose. The medical composition has the advantages of simple preparation process, definite and stable therapeutic effect, convenient administration and broad spectrum, and may be used to prepare the medical preparations for preventing and treating duck infectious serositis. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Quality Control of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
The Article related to sulfamethoxazole sodium trimethoprim lactate maquindox duck infectious serositis preparation, Pharmaceuticals: Formulation and Compounding and other aspects.Quality Control of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia